Thursday, November 10, 2022
10amPT/1pmET (Duration = 30 Minutes)

Join Ipsos for an introduction to the complex, fast-moving world of oncology.

Delivered by Ipsos’ Oncology Center of Expertise, this introductory session will inform and equip pharmaceutical professionals who are new to oncology marketing or marketing research – or looking to enter this therapy area. Specifically, our complimentary webinar will provide a concise overview of:

  • What is Cancer: the disease, its prevalence and its causes
  • Types of Cancer: solid tumors versus hematological malignancies
  • Staging: staging and classification systems by cancer type
  • Treatment Overview: treatment approaches and drivers of treatment choice
  • Precision Medicine: biomarkers and targeted agents
  • Immuno-Oncology: novel agents and future innovations
  • Implications: considerations for marketing and MR professionals.

Don’t miss out – register today! 

We expect you’ll find this session enlightening and gain a foundational understanding of this highly complex disease.

 
Thursday, November 10, 2022
10amPT/1pmET (Duration = 30 Minutes)

Join Ipsos for an introduction to the complex, fast-moving world of oncology.

Delivered by Ipsos’ Oncology Center of Expertise, this introductory session will inform and equip pharmaceutical professionals who are new to oncology marketing or marketing research – or looking to enter this therapy area. Specifically, our complimentary webinar will provide a concise overview of:

  • What is Cancer: the disease, its prevalence and its causes
  • Types of Cancer: solid tumors versus hematological malignancies
  • Staging: staging and classification systems by cancer type
  • Treatment Overview: treatment approaches and drivers of treatment choice
  • Precision Medicine: biomarkers and targeted agents
  • Immuno-Oncology: novel agents and future innovations
  • Implications: considerations for marketing and MR professionals.

Don’t miss out – register today! 

We expect you’ll find this session enlightening and gain a foundational understanding of this highly complex disease.

 
Register Today
Presenters
Eric Blouin
Ipsos Oncology Center of Expertise (North America)

Amy Butcher
Ipsos Oncology Center of Expertise (UK)
Ibi victu recreati et quiete, postquam abierat timor, vicos opulentos adorti equestrium adventu cohortium, quae casu propinquabant, nec resistere planitie porrecta conati digressi sunt.
Earlene Worrall
Partner, Ipsos Healthcare Advisory, Positioning Strategy Expert
Ibi victu recreati et quiete, postquam abierat timor, vicos opulentos adorti equestrium adventu cohortium, quae casu propinquabant, nec resistere planitie porrecta conati digressi sunt.
Ibi victu recreati et quiete, postquam abierat timor, vicos opulentos adorti equestrium adventu cohortium, quae casu propinquabant, nec resistere planitie porrecta conati digressi sunt.
Ibi victu recreati et quiete, postquam abierat timor, vicos opulentos adorti equestrium adventu cohortium, quae casu propinquabant, nec resistere planitie porrecta conati digressi sunt.
Ibi victu recreati et quiete, postquam abierat timor, vicos opulentos adorti equestrium adventu cohortium, quae casu propinquabant, nec resistere planitie porrecta conati digressi sunt.
Ibi victu recreati et quiete, postquam abierat timor, vicos opulentos adorti equestrium adventu cohortium, quae casu propinquabant, nec resistere planitie porrecta conati digressi sunt.
Ibi victu recreati et quiete, postquam abierat timor, vicos opulentos adorti equestrium adventu cohortium, quae casu propinquabant, nec resistere planitie porrecta conati digressi sunt.
Ibi victu recreati et quiete, postquam abierat timor, vicos opulentos adorti equestrium adventu cohortium, quae casu propinquabant, nec resistere planitie porrecta conati digressi sunt.